Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts


More Industry Headlines

FDA orders duodenoscope makers to conduct safety studies Manufacturers responsible for monitoring end user cleaning compliance

Colorectal cancer screening too aggressive for certain people: researchers Risk among patients with family history gets progressively smaller with age

Trice and FUJIFILM SonoSite develop imaging-sharing portable ultrasound Embedded communication is the way of the future

Kentucky Trailer rolls on with acquisition of Smit Mobile Equipment Will expand mobile medical footprint internationally

Half of all late-stage lung cancer patients are over-treated with radiation New study raises concerns regarding financial motivation

Medical Museum: Medical Chest Learn more about a vintage medical chest from an early 19th century pharmacist

Jan Kimpen appointed CMO of Royal Philips Worked at UMC Utrecht for 15 years

Using 7T MR to bring the brain's visual cortex into unprecedented focus Researchers see promise for unlocking mystery of mental disorders

UCLA not responsible for patient record release, could set legal precedent Doctors sharing access against facility rules not fault of institution

Texas MakerHealth Space will facilitate the creation of care solutions by nurses Providing tools from 3-D printers to Velcro

Dr. Frederic Fahey,
past president of SNMMI

Dose awareness isn't just for CT

by Carol Ko , Staff Writer
Ever since a few high-profile stories put CT dose under the media microscope in 2009, dose scrutiny has spilled over into other modalities — namely molecular imaging. Both governmental agencies like the Food and Drug Administration and the public have consequently expressed more interest in the topic.

"In Boston Children's Hospital, I see parents asking more questions about radiation, its risks, and what it means for their child," Dr. Frederic Fahey, past president-elect of 2012 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), told DOTmed News. Indeed, concern around radiation dose is commonly cited as one of the barriers to growth in the molecular imaging market.

Story Continues Below Advertisement

What's the best path to the future of better health? YOURS.

The best way to navigate the evolving healthcare landscape is on a clear path. McKesson’s customizable solutions for radiology & cardiology are scalable to suit your exact size and complexity and provide standards-based integrations.Click for more info

Recognizing that dose awareness in molecular imaging is in its relative infancy, Fahey and colleague Dr. Adam Alessio, associate professor at the Imaging Research Laboratory at the University of Washington and Fahey's co-chair for the SNMMI Dose Optimization Working Group, endeavored to organize initiatives during Fahey's presidency that would help move dose awareness forward in the field.

Ultimately, the organization's goal is to help provide practitioners with as much information on dose optimization as it can — a goal that's easier said than done, since there are some logical hurdles to overcome around collecting that information.

For good measure

For example, SNMMI recently worked with the Intersocietal Accreditation Commission (IAC) to help do something that had been only done on a smaller scale before: collect data to see how much levels of radiation dose varied from center to center for the same scan — more specifically, PET and bone scans.

The society gathered and analyzed data submitted to the IAC from sites seeking accreditation — a total of 225 sites that performed MDP bone scans and 95 sites that performed FDG PET scans.

Though on average the median levels of radiation dose fell squarely in line with the levels recommended by the society, there was significant individual variation. On the bone scan side, one patient received 19 millicuries of radiation for another patient's 36. And the radiation levels for PET scans ranged from 3 to 23 millicuries, though the suggested range is 10-20.

Fahey cautions that the data might be biased, since centers that seek accreditation might be more scrupulous in their dose administration than centers that don't, but the study is still the largest review of its sort.

Manual labor

On the manufacturing end, CT dose reduction efforts have been met with measurably significant success, as there's been a big market to satisfy increased demand for lower dose technologies. But whether this momentum will translate over to molecular imaging is questionable.

Continue reading Dose awareness isn't just for CT...
  Pages: 1 - 2 >>


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Mohan Doss

Dose reduction efforts in nuclear medicine are misguided

September 05, 2013 05:02

For diagnostic nuclear medicine, there has not been even a single report that has shown increased cancer risk from radiotracer usage. So, what are the dose reduction efforts going to gain us in terms of reduced cancers? Reduction of excess cancers from zero to zero? How can anyone justify all the dose reduction efforts, with no health benefit to patients?

Though dose reduction has been recommended by many leading scientists, government agencies, and the various professional organizations as being prudent based on the linear no-threshold (LNT) model, there is increasing amount of evidence for the invalidity of the LNT model and for the beneficial effects of low dose radiation including prevention of cancer and neurodegenerative diseases. So, there is no benefit to patients in terms of reduced cancer risks from these dose reduction efforts. Aggressive dose reduction efforts can result in poorer image quality, and this has been described in reports of dose reduction efforts in a recent meeting.

Such dose reduction efforts also tend to validate the current popular superstitious belief about the carcinogenicity of low dose radiation, and discourages and prevents study of its beneficial effects.

In view of the above, I would suggest suspending the current dose monitoring/reduction efforts, and return our focus to improving the image quality and diagnosis.

Mohan Doss

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2015, Inc.